Business
SYNT: Q3 sales fell 7% with a large impairment, but strategic moves set up a Q4 growth rebound
SYNT: Q3 sales fell 7% with a large impairment, but strategic moves set up a Q4 growth rebound
About this update from Syntheticmr Ab
Q3 2025 saw a 7% sales decline and a significant operating loss, mainly due to a SEK 18.5 million impairment. The Combinostics acquisition and regulatory approvals in Asia strengthen future prospects, with a return to growth expected in Q4.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.